|
MabVax Therapeutics Enters Into Exchange Agreements To Issue Common …
MarketWatch … MabVax Therapeutics Holdings, Inc. (otcqb:MBVX), acancer diagnostic and immunotherapy company, today announced that it had successfully restructured approximately $5.2 Million of outstanding Series A-1and B convertible preferred stock and warrants … |
